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Background: The human ACTN3 gene encodes α-actinin-3, an actin-binding protein with a pivotal role in muscle
structure and metabolism. A common genetic single nucleotide polymorphism (SNP) at codon 577 of the ACTN3
results in the replacement of an arginine (R) with a stop codon (X). The R allele is a normal functional version of the
gene, whereas the X allele contains a sequence change that completely stops production of functional α-actinin-3
protein. The ACTN3 R577X polymorphism was found to be associated with power athletic performance especially
among track and field athletes. The aim of the current study was to compare allelic and genotype frequencies of
the ACTN3 R577X polymorphism among runners and swimmers specializing in different distances, and >non-athletic
controls.
Methods: One hundred and thirty-seven runners, 91 swimmers and 217 controls, participated in the study. Runners
were assigned to two subgroups according to their event specialty—long-distance runners (LDR) and short-distance
runners (SDR). Swimmers were also assigned to two subgroups according to their main swimming event—long-distance
swimmers (LDS) and short-distance swimmers (SDS). Genomic DNA was extracted from peripheral EDTA-treated
anti-coagulated blood using a standard protocol. Genotypes were determined using the Taqman allelic
discrimination assay.
Results: Runners’ genotype and allele differed significantly between LDR, SDR, and controls, with the lowest
prevalence of RR genotype and R allele among LDR. XX genotype and X allele prevalence was significantly higher
among LDR compared to the other groups (p < 0.01 for all). On the other hand, swimmers’ genotype and allele
frequencies did not differ significantly between subgroups (LDS and SDS). Yet, LDS had significantly higher RR
genotype and R allele frequencies compared to LDR.
Conclusions: The findings suggest that while ACTN3 R577X polymorphism is a genetic polymorphism that may
distinguish between SDR and LDR, it cannot differentiate significantly between SDS and LDS.
Trial Registration: ClinicalTrials.gov: NCT01319032
Key Points:
 ACTN3 R577X polymorphism is largely associated with running events specialization, with high prevalence of
RR genotype and R allele frequency among short-distance runners compare to long-distance runners.
 Unlike in running, ACTN3 R577X polymorphism is not associated with swimming specialization.
 The inability of the ACTN3 R577X polymorphism to distinguish between swimmers specializing in different
events, presumably since other factors such as body physique, technique, tactics, etc., are more likely to
determine such a distinction.
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Athletic performance is a multifactorial trait, determined
by a range of genetic and environmental factors. Most of
the genetic polymorphisms considered to be related to
athletic performance were investigated in case-control
retrospective studies [1], which did not reveal the bio-
logical mechanism responsible for the influence of this
polymorphism on athletic performance. Moreover, most
of these polymorphisms are intronic and non-functional.
The ACTN3 R577X (rs1815739) polymorphism is an
exception in this sense, since it is a well-studied func-
tional polymorphism. The human ACTN3 gene encodes
α-actinin-3, an actin-binding protein with a structural
role at the sarcomeric Z-line in glycolytic (type II, fast-
twitch) muscle fibers, and plays an increasingly evident
role in the regulation of muscle metabolism [2]. A com-
mon genetic single nucleotide polymorphism (SNP) at
codon 577 of the ACTN3 results in the replacement of
an arginine (R) with a stop codon (X) [3]. The R allele is
a normal functional version of the gene, whereas the X
allele contains a sequence change that completely stops
production of functional α-actinin-3 protein [3]. There-
fore, XX homozygotes do not express ACTN3 at all in
their muscles [2]. In the knockout mouse, it is clear that
ACTN3 deficiency alters skeletal muscle function [2].
Yang et al. [4] demonstrated, for the first time, a sig-
nificant association between the ACTN3 genotype and
athletic performance. They found that both male and fe-
male elite sprint athletes have significantly higher fre-
quencies of the 577R allele compared to controls. Since
then ACTN3 R577X has been studied in various co-
horts. Some articles have reported a strong association
between the RR genotype and elite power performance
[5–8]. While ACTN3 R carriage may enhance power
performance, ACTN3 XX might contribute to endur-
ance performance [9, 10]. However, reports on Asians
and Africans suggested that ACTN3 deficiency might
not be associated with endurance performance [11, 12].
A recent meta-analysis of 88 articles did not find a sig-
nificant association for ACTN3 RR genotype with phys-
ical performance (odds ratio (OR), 1.03; 95 % confidence
interval (CI), 0.92–1.15). However, when the analysis
was restricted to power events, a significant association
was observed (OR, 1.21; 95 % CI, 1.03–1.42) [13]. Over-
all, association studies on ACTN3 R577X polymorphism
and power performance show consistent results across
multiple athlete cohorts [14]. Moreover, unlike many
polymorphisms, the ACTN3 R577X polymorphism is a
functional polymorphism, with the XX genotype result-
ing in complete loss of function. A mechanistic explan-
ation for the role of ACTN3 in power performance can
be found in the α-actinin-3 knockout (KO) mouse. Com-
pared with wild-type mice, the muscles of the KO mouse
exhibit reduced muscle mass, due to decreased diameterof fast muscle fibers, significant decrease in grip strength,
higher endurance, and a shift towards increased activity of
mitochondrial oxidative metabolism [9, 10]. All of these
placed the ACTN3 R577X polymorphism as a pivotal
polymorphism explaining power athletic performance [14].
Interestingly, while the ACTN3 R577X polymorphism
has been studied extensively among track and field ath-
letes (especially runners), its contributions to perform-
ance in swimming, a sport that muscle strength plays
also a key role [15], had received little attention. In
swimming, muscular strength dictates how much force
muscles are able to apply to the water, which in turn
propels the body forward. Therefore, muscular strength
is of great importance in order to produce speed in
sprint swimming, while in endurance swimming muscu-
lar strength is required to perform repeated submaximal
contractions over time. The few studies that investigate
ACTN3 R577X prevalence among swimmers did not
find significant association between the ACTN3 R577X
polymorphism and swimming performance among Cau-
casian, East Asians [16], or Spanish swimmers [17].
Among Taiwanese, the R allele was significantly higher
in female international sprint swimmers than in national
sprint swimmers or the general population [5].
Therefore, the aim of the current study was to com-
pare allelic and genotype frequencies of the ACTN3
R577X polymorphism among runners and swimmers
specializing in different distances, and non-athletic con-
trols. We hypothesized that similarly to runners, the R
allele will be more frequent among sprint swimmers and
the X allele more frequent among endurance swimmers.
Methods
Participants
One hundred and thirty-seven track and field athletes
(98 males and 39 females, age 17–50) and 91 swimmers
(60 males and 31 females, age 16–49) participated in the
study. The track and field athletes were assigned to two
subgroups according to their event specialty, as follows:
1) long-distance runners (5000 m marathon runners—LDR)
(n = 65) and 2) power event athletes (100–200 m sprinters
and long jumpers—SDR) (n = 72). The swimmers were also
assigned to two groups according to their main swimming
event, as follows: 1) long-distance swimmers (800–1500 m
swimmers—LDS) (n = 43) and 2) short-distance swimmers
(50–100 m swimmers—SDS) (n = 48). All athletes were
ranked among the top Israeli results in their event and had
competed in national and/or international level meets on a
regular basis. Sixty-seven track and field athletes were clas-
sified as international athletes (participants in European
and World Championships, and Olympic Games). The
Israeli runners’ criteria for participation in the Olympic
Games and World championships are ranking in places 1–
12 in the former European championship or 1–16 in the
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2 years prior to the upcoming event), or setting the inter-
national result criteria A at least once. For participation in a
European championship, the runners should fulfill the
above criteria or set the international result criteria B at
least twice. The international results criteria A and B are
standard results published yearly by the IAAF (The Inter-
national Association of Athletic Federation, http://www.iaa-
f.org/). These standard results are intended to qualify
athletes to be eligible to compete in Olympics and World
Championships. The A standard is the most difficult to
achieve. The B standard is easier to achieve, and usually, na-
tional athletic association uses it also as a criterion to inter-
national competition participation.
Thirty-one swimmers were classified as international
athletes (participants in European and World Champi-
onships, and Olympic Games). The Israeli swimmers re-
sult criteria for participation in the European and World
championships and in the Olympic Games are the aver-
age result of the 16th place in the former three respect-
ive championships. These criteria indicate a remarkable
difference between the international and national level
athletes in the present study. The control group con-
sisted of 217 (137 males and 80 females, age 19–29)
non-athletic healthy individuals who were not engaged
in competitive sport. Characteristics of the athletes and
controls are presented in Table 1.
The study was approved by the Institutional Review
Board of the Hillel Yaffe Medical Center, Hadera, Israel,
according to the Declaration of Helsinki. A written in-
formed consent was obtained from all participants.
Genotyping
Genomic DNA was extracted from peripheral EDTA-
treated anti-coagulated blood using a standard protocol.
Genotypes were determined using the Taqman allelic
discrimination assay. The Assay-by-Design service
(www.appliedbiosystem.com) was used to set up a
Taqman allelic discrimination assay for the ACTN3
(rs1815739 C1747T). Primer sequences were as follows:
forward, GCACGATCAGTTCAAGGCAAC; reverse,
GCTGAGGGTGATGTAGGGATTG. Probe sequences
were for C1747T: forward, VIC-CGAGGCTGACCGA-
GAG; reverse, FAM-CCGAGGCTGACTGAGAG. The
PCR reaction mixture included 5 ng genomic DNA,
0.125 μl TaqMan assay (40*, ABI), 2.5 μl Master mix
(ABI), and 2.375 μl water. PCR was performed in 96 well
PCR plates in an ABI 7300 PCR system (Applied Biosys-
tems Inc., Foster City, CA, USA) and consisted of initial
denaturation for 5 min at 95 °C, and 40 cycles with de-
naturation of 15 s at 95 °C and annealing and extension
for 60 s at 63 °C. The results were analyzed by the ABI
Taqman 7900HT using the sequence detection system
2.22 software (Applied Biosystems Inc).Statistical Analysis
The SPSS statistical package, version 20.0, was used to
perform all statistical evaluations (SPSS, Chicago, IL,
USA). A chi-squared test was used to confirm that the
observed genotype frequencies were in Hardy-Weinberg
equilibrium and to compare alleles and genotype frequen-
cies between athletes and controls, as well as between ath-
letes from different sports (e.g., runners vs. swimmers) and
different competitive groups (e.g., sprinters vs. endurance).
If observed or expected values included a cell value of 5,
we used Fisher’s exact test to compare alleles and genotype
frequencies.
Results
The complete data on allele and genotype frequencies
are presented in Table 2. The genotype subtype did not
differ by age or sex. The ACTN3 genotype distribution
was in agreement with the Hardy-Weinberg equilibrium
in all groups (p = 0.87 for LDR, p = 0.84 for SDR, p =
0.99 for LDS, p = 0.78 for SDS, and p = 0.13 for
controls).
Runners’ genotype and allele frequencies are presented
in Fig. 1. The runners’ genotype differed significantly be-
tween long-distance runners, short-distance runners,
and controls (p < 0.01 for LDR vs. SDR, LDR vs. con-
trols, and SDR vs. controls). The long-distance runners
had the lowest frequency of RR genotype (20.0 % com-
pared to 40 % among SDR). This frequency was similar
to the RR genotype frequency among controls (22.1 %).
On the other hand, the XX genotype frequency was sig-
nificantly higher among LDR (35.4 %) compared to the
other groups, SDR (16.7 %), and controls (18.4 %). LDR
had a significantly higher frequency of X allele (57.7 %)
compared to SDR (38.2 %, p < 0.01). SDR had significant
higher R allele frequency (61.8 %) compared to LDR
(42.3 %, p < 0.001) and controls (51.8 %, p < 0.05).
The swimmers’ genotype and allele frequencies are
presented in Fig. 2. The swimmers’ genotype and allele
frequencies did not differ significantly between the
specialization subgroups (LDS and SDS). Yet, the swim-
mers’ genotype frequency differed significantly from the
controls (p < 0.05). LDS’ and SDS’ RR genotype frequen-
cies (37.5 and 37.2 %, respectively) were significantly
higher compared to controls’ RR genotype frequency
(22.1 %, p < 0.01 for LDS vs. controls and p < 0.03 for
SDS vs. controls). LDS had higher XX genotype fre-
quency (18.7 %) compared to SDS (11.6 %), but this dif-
ference did not reach statistical significance.
We compared allele and genotype frequencies between
athletes specializing in endurance-type events from dif-
ferent sports (e.g., LDS vs. LDR) and between athletes
specializing in power-type events from different sports
(e.g., SDS vs. SDR). LDS had significantly higher RR
genotype and R allele frequency (37.4 and 59.3 %,
Table 1 Athletes and controls’ data
Group Number Main event M/F Top/national level Age (mean + SD, range)
Runners
Long distance 65 5000 m marathon 50/15 21/44 31.4 + 9.2 (17–50)
Power event (sprinters and jumpers) 72 100–200 m, jumps 48/24 23/49 30.1 + 12.7 (17–50)
Swimmers
Long distance 43 800–1500 m 27/16 15/28 23.6 + 7.9 (16–49)
Short distance 48 50–100 m 33/15 16/32 23.3 + 8.3 (16–48)
Controls 217 nr 137/80 nr 26.4 + 5.8 (19–29)
nr not relevant
Ben-Zaken et al. Sports Medicine - Open  (2015) 1:13 Page 4 of 8respectively) compared to LDR (20.0 and 42.3 %,
respectively) (p < 0.04 and p < 0.04 for RR genotype and
R allele frequency, respectively) (Fig. 3). The power-type
athletes’ genotype and allele frequencies did not differ
significantly between SDR and SDS.
Discussion
The main finding of the current study is that while the
ACTN3 R577X polymorphism was largely associated
with a distinction between runners specializing in sprint
events compared to runners specializing in long-distance
events, this difference was not found among swimmers
specializing in sprint events compared to swimmers spe-
cializing in long-distance events.
Athletic events can be divided by the distance or time
of the activity. Other parameters, like power, speed, and
endurance, are also used to characterize specific sports.
Track and field is a good example of the use of these
descriptors and their activity time frames in differentiating




Long distance 65 13(20.0)*,** 29(44.6
Short distance 72 29(40.3)*** 31(43.1
Total 187 57(30.5) 86(46.0
Swimmers
Long distance 48 18(37.5)#, ^ 18(37.5
Short distance 43 16(37.2)^^ 22(51.2
Total 91 34(37.4) 40(43.9
Controls 217 48(22.1) 129(59
Values are absolute (relative frequencies in parentheses)
*χ2(2) = 8.50, p < 0.01, genotype frequency, LDR vs. controls
**χ2(2) = 9.29, p < 0.01, genotype frequency, LDR vs. SDR
***χ2(2) = 9.41, p < 0.01, genotype frequency, SDR vs. controls
#χ2(2) = 8.01, p < 0.02, genotype frequency, LDS vs. controls (χ2(1) = 6.14, p < 0.01, RR
^χ2(1) = 4.25, p < 0.04, RR genotype, LDR vs. LDS
^^χ2(1) = 4.97, p < 0.03, RR genotype, SDS vs. controls
¥¥χ2(1) = 10.42, p < 0.001, allele frequency, LDR vs. SDR
¥¥¥χ2(1) = 4.32, p < 0.05, allele frequency, SDR vs. controls
&χ2(1) = 4.30, p < 0.04, allele frequency, LDR vs. LDStype athletic events are characterized by relatively low-in-
tensity, long-lasting exercise that relies primarily on the
aerobic energy-generating process [18]. The term aerobic
refers to the use of oxidative phosphorylation to ad-
equately meet energy demands during exercise [19]. In
contrast, strength, power, and speed-type athletic events
are characterized by intense efforts lasting a short time
and by the use of anaerobic metabolism as the energy
source.
The ACTN3 R577X polymorphism is a well-docu-
mented genetic marker that enables sport scientists to
distinguish between a genetic predisposition towards ex-
cellence in power-type events or in endurance-type
events [14]. Indeed, in the present study we found a sig-
nificant difference in ACTN3 R577X polymorphism
prevalence among LDR compared to SDR, with a high
prevalence of 40.3 and 61.8 % for RR genotype and R al-
lele frequency in SDR compared to 20.0 and 42.3 % for
RR genotype and R allele frequency in LDR. This finding
may suggest that the ACTN3 R577X polymorphismoups
Allele frequency
X/X R allele X allele
)*,** 23(35.4)*,** 55(42.3)¥, ¥¥ 75(57.7)¥, ¥¥
)*** 12(16.7)*** 89(61.8)¥¥¥ 55(38.2)¥¥¥
) 44(23.5) 200(53.5) 174(46.5)
)# 12(25.0)# 57(57.0)& 43(43.0)&
) 5(11.6) 55(62.5) 33(37.5)
) 17(18.7) 108(59.3) 74(40.7)
.4) 40(18.4) 225(51.8) 209(48.2)
genotype, SDS vs. controls
Fig. 1 The ACTN3 R577X polymorphism a genotype frequencies, b allele frequencies in track and field athletes and controls. *χ2(2) = 8.50, p < 0.01,
genotype frequency, LDR vs. controls. **χ2(2) = 9.29, p < 0.01, genotype frequency, LDR vs. SDR. ***χ2(2) = 9.41, p < 0.01, genotype frequency, SDR vs.
controls. #χ2(1) = 3.64, p = 0.06, allele frequency, LDR vs. controls. ##χ2(1) = 10.42, p < 0.001, allele frequency, LDR vs. SDR. ###χ2(1) = 4.32, p < 0.05, allele
frequency, SDR vs. controls
Ben-Zaken et al. Sports Medicine - Open  (2015) 1:13 Page 5 of 8enables to distinguish between two types of track and
field events—a “pure power event” and a “pure endur-
ance event.” Yet, for a higher resolution distinction like
the one needed to distinguish between middle-distance
runners (MDR) and LDR performance, or between MDR
and SDR performance, other genetic markers or profiles
may be needed. This assumption should be examined in
future studies. Since swimming events are also divided
by the distance or time of the activity, one would assume
that swimming events can also be classified into “endur-
ance-type events” and “power-type events.” Subsequently,
the genetic background that influences a track and fieldathlete’s capability to excel in one sport discipline (e.g.,
sprint running) rather than another (e.g., long-distance
running) would, presumably, be similar to the genetic
background that influences a swimmer’s capability to excel
in a specific sport discipline. However, in contrast to our
hypothesis, no significant association was found in the
present study between the ACTN3 R577X polymorphism
and swimming performance. This finding is consistent
with previous reports that failed to find an association be-
tween the ACTN3 R577X polymorphism and swimming
performance in Caucasians, East Asians [16], and Spanish
swimmers [17]. In contrast, R allele was significantly
Fig. 2 The ACTN3 R577X polymorphism (a genotype frequencies, b allele frequencies) in swimmers and controls. *χ2(2) = 8.01, p < 0.02, genotype
frequency, LDS vs. controls. **χ2(1) = 4.97, p < 0.03, RR genotype, SDS vs. controls
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compared to national-level sprint swimmers and the gen-
eral population [5].
ACTN3 plays a pivotal role in muscle metabolism,
structure, and fiber-type distribution [2, 20], and therefore
it has a direct effect on the ability to perform in elite
power events. However, based on the present findings, it
may be that none of these are detrimental to swimming. It
may be that the aspect of power performance affected by
the polymorphism is less important in swimming relative
to other sports, possibly because of the relatively lower
stress put on muscles supported in water and the lack of
eccentric contractions [21]. Moreover, in swimming the
produced power is lower compared to land activities of
similar duration [22]. Efficiency is a critical factor in this
sport, which includes several aspects of technique.Swimming is a highly skilled sport, where the neural and
biomechanical skills are the greatest contributor for force
production [22–24]. Overall, in swimming, the athlete’s
technique and body physique have a greater impact on
performance than in other sports such as running.
In line with this, we have previously found a strong
significant correlation (r = 0.74) between 100 m and the
2000 m swim times suggesting that swimming times are
largely affected by swimming technique and by the
swimmers’ size (particularly limb length) [25]. These
may, at least partially, mask metabolic differences be-
tween swimmers, enabling technically skilled and/or tall
swimmers to excel at all swimming distances. These rela-
tionships are unique for swimming, and this assumption
can be supported by the past records of top world-class
swimmers, such as Ian Thorpe (world record holder in
Fig. 3 The ACTN3 R577X polymorphism (a genotype frequencies, b
allele frequencies) in endurance athletes (LDR and LDS). *χ2(1) = 4.25,
p < 0.04, RR genotype, LDR vs. LDS. #χ2(1) = 4.30, p < 0.04, allele
frequency, LDR vs. LDS
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Grant Hackett (world record holder in 200-m relays and
individual 400, 800, and 1500 m), as well as others who
excel in both short and long swimming distances. A simi-
lar phenomenon is very uncommon among runners. To
the best of our knowledge, this relationship between
short- and long-distance performances in swimming has
not been reported previously in other sport types.
Lastly, there is the possibility that a type II error ac-
counts for the fact that we do not see an association
between the ACTN3 R577X polymorphism and swim-
ming performance. Large studies with the power to
detect significant associations at genome-wide level
have not yet been conducted. Although a meta-
analysis of the association between ACTN3 and
sprint/power athlete status demonstrated evidence for
a real association [13, 26], many studies—mainly with
small sample sizes—have failed to observe anyassociation between ACTN3 variants and sporting
performance.
It should be noted that both LDS and SDS had a
higher RR genotype frequency (38.0 and 36.4 %, respect-
ively) compared to controls (22.1 %). This result implies
that both LDS and SDS may benefit from ACTN3 R
allele existence, strengthening the notion of no clear
ACTN3 polymorphism differences between power and
endurance swimmers. Moreover, RR genotype and R
allele frequency were higher among LDS (38.0 and
57.0 % for RR genotype and R allele frequency, respect-
ively) compared to LDR (20.0 and 42.3 % for RR geno-
type and R allele frequency, respectively). This may be
explained by differences in the specific activity duration
of competitive swimming and running. The longest
Olympic swim (1500 m ~ 15 min duration) is much
shorter than the longest Olympic running race (mara-
thon ~2 h 10-min duration), and therefore ACTN3
power characteristics are needed for long-distance swim-
mers. It is possible that if open-water swimmers (Olympic
race—10K) had been included among the long-distance
swimmers in the present study, the differences in the R al-
lele frequency between LDS and LDR would disappear.
When comparing the short-duration events, there is also a
difference in the specific activity duration of competitive
swimming and running. The 100-m distance covered in
swimming at approximately 50 s, while the same distance
covered in running at approximately 10 s. As a result, a
sprint runner relies mostly on anaerobic energy sources,
while a sprint swimmer uses also aerobic energy compo-
nents. Therefore, the SDS and the LDS share some com-
mon features, and the ACTN3 RR genotype is not suitable
as a distinguishing genetic marker between them, as it
does for SDR and LDR.Conclusions
To conclude, the findings of the present study propose
that while the ACTN3 R577X polymorphism is a genetic
polymorphism that may distinguish between SDR and
LDR, it cannot differentiate significantly between SDS
and LDS. This suggests that the power of a specific
genetic factor to serve as the sole divider between ath-
letes of different specialties—aerobic or anaerobic—is
limited. It seems that body physique, technique, tactics,
and psychological factors are more likely to influence
and determine such a distinction, especially in certain
sport types, like swimming.
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